| ||
| Glaxo to Shed Its OTC Diet Drug, Alli Wall Street Journal By JEANNE WHALEN Four years after launching the nonprescription diet pill Alli with much fanfare and a heavy marketing budget, UK drug maker GlaxoSmithKline PLC on Thursday said that it plans to sell off the drug along with a clutch of other ... See all stories on this topic » | ||
|
Tip: Use site restrict in your query to search within a site (site:nytimes.com or site:.edu). Learn more.
Remove this alert.
Create another alert.
Manage your alerts.

No comments:
Post a Comment